Bacteroides thetaiotaomicron - 4D PharmaAlternative Names: Thetanix
Latest Information Update: 15 Mar 2016
At a glance
- Originator GT Biologics
- Developer 4D Pharma PLC
- Class Bacteria
- Mechanism of Action Bacteria replacements; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Crohn's disease
Most Recent Events
- 01 Dec 2015 Phase-I clinical trials in Crohn's disease (In adolescents) in United Kingdom (PO) (NCT02704728)